Yaqrit as part of the ALIVER Consortium announces completion of first randomised controlled study of DIALIVE for ACLF at EASL’s Digital International Liver Congress


You May Also Like

MacroGenics to Present at the 35th Annual J.P. Morgan Healthcare Conference

ROCKVILLE, MD, Jan. 05, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage ...

Surgery Partners, Inc. Announces Third Quarter 2015 Results

NASHVILLE, Tenn., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (or the "Company"), ...